Statistics for Soleno Therapeutics (id:5920 SLNO)

Valuation metrics

Market cap

2.23B

Enterprise value

1.98B

Trailing P/E (ttm)

-24.48

Forward P/E

-22.75

PEG ratio

-22.75

Price/Sales (ttm)

Price/Book (mrq)

8.01

Enterprise Value/Revenue

Enterprise Value/EBITDA

-14.50

Overview

Shares outstanding

43.12M

Float

27.54M

Shares short

6.17M

% Held by insiders

0.03%

% Held by institutions

1.04%

Average volume (10 days)

535.31K

Average volume (90 days)

Price summary

52-Week low

26.38

52-Week high

59.75

52-Week change

50.04%

Beta

-1.44

50-Day moving average

52.74

200-Day moving average

46.83

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

October 06th, 2017

Ex-dividend date

Last split factor

2:1

Last split date

August 26th, 2022

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-48.05%

Return on equity

-91.11%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-136,496,000.00

Net income to common (ttm)

-131,164,000.00

Diluted EPS (ttm)

-2.79

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

256.78M

Total cash per share (mrq)

5.96

Total debt (mrq)

3.03M

Total Debt/Equity (mrq)

1.14

Current ratio (mrq)

1.73K%

Book value per share (mrq)

6.45

Cash flow

Cash flow statement

-51,419,000.00

Levered free cash flow (LFCF)

-27,092,124.00